Fuhrman Alan 4
4 · Tyra Biosciences, Inc. · Filed Aug 1, 2023
Insider Transaction Report
Form 4
Fuhrman Alan
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-07-28+62,685→ 62,685 totalExercise: $14.35Exp: 2033-07-27→ Common Stock (62,685 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option will vest on July 28, 2024, and 1/48th of the shares subject to the option vest monthly thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date.